How is Humanin administered?
This describes how Humanin is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a daily schedule, generally over 4-8 weeks. Specific dosing is individual and beyond general information, and human evidence for Humanin is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Daily
- Cycle length: 4-8 weeks
- Half-life: ~minutes (rapid clearance)
References
- Humanin: a harbinger of mitochondrial-derived peptides — Lee C et al., Trends Endocrinol Metab, 2013
- Humanin: a novel central regulator of peripheral insulin action — Muzumdar RH et al., PLoS One, 2009
- Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives — Karachaliou CE & Livaniou E, Biology (Basel), 2023
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Humanin
Last updated 2026-06-15.